Q32 Bio Inc.QTTBNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank44
3Y CAGR-76.3%
5Y CAGR-73.7%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
-76.3%/yr
vs -44.1%/yr prior
5Y CAGR
-73.7%/yr
Consistent
Acceleration
-32.2pp
Decelerating
Percentile
P44
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthCompressed
PeriodValueYoY Change
20250.15-
20240.00+100.0%
2023-9.09-182.6%
202211.00+220.0%
20213.44-97.1%
2020117.08-76.2%
2019491.03+335.4%
2018112.78-
20170.00-
20160.00-